APA

Nadar R. A., Farbod K., der Schilden K. C., Schlatt L., Crone B., Asokan N., Curci A., Brand M., Bornhaeuser M., Iafisco M., Margiotta N., Karst U., Heskamp S., Boerman O. C., van den Beucken J. J. J. P. & Leeuwenburgh S. C. G. (20201125). Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity. : Scientific reports.

Chicago

Nadar Robin A, Farbod Kambiz, der Schilden Karlijn Codee-van, Schlatt Lukas, Crone Barbara, Asokan Nandini, Curci Alessandra, Brand Michael, Bornhaeuser Martin, Iafisco Michele, Margiotta Nicola, Karst Uwe, Heskamp Sandra, Boerman Otto C, van den Beucken Jeroen J J P and Leeuwenburgh Sander C G. 20201125. Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity. : Scientific reports.

Harvard

Nadar R. A., Farbod K., der Schilden K. C., Schlatt L., Crone B., Asokan N., Curci A., Brand M., Bornhaeuser M., Iafisco M., Margiotta N., Karst U., Heskamp S., Boerman O. C., van den Beucken J. J. J. P. and Leeuwenburgh S. C. G. (20201125). Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity. : Scientific reports.

MLA

Nadar Robin A, Farbod Kambiz, der Schilden Karlijn Codee-van, Schlatt Lukas, Crone Barbara, Asokan Nandini, Curci Alessandra, Brand Michael, Bornhaeuser Martin, Iafisco Michele, Margiotta Nicola, Karst Uwe, Heskamp Sandra, Boerman Otto C, van den Beucken Jeroen J J P and Leeuwenburgh Sander C G. Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity. : Scientific reports. 20201125.